欧洲疾控中心：欧盟/欧洲经济区（EARS-Net）的抗菌素耐药性2024年年度流行病学报告（英文版）

In 2024, the estimated total EU incidence of meticillin-resistant Staphylococcus aureus (MRSA) bloodstream infections was 4.48 per 100 000 population (EU country range 0.55−13.63). This was 20.4% lower than in 2019 (baseline year) and 0.31 per 100 000 population lower than the 2030 target of 4.79 per 100 000 population. For the EU overall, a statistically significant decreasing trend was detected between 2019 (baseline year) and 2024. • The estimated total EU incidence of third-generation cep